“Made by Solaray — over 50 years of supplement experience.”
Solaray was founded in 1973 — verifiable corporate history with 50+ years of continuous operation as of 2026. The brand-heritage claim is literal historical fact.

FrontThe legacy-brand pick — 50-year US reputation, with a declared but low 7 mg (1.5%) withanolides per cap.
Solaray Ashwagandha is the legacy-brand pick for buyers who weight 50+ years of US supplement reputation + broad offline distribution over patent-extract standardisation. Solaray was founded in 1973 and has built into nearly every health food store in America — Sprouts, Whole Foods, Vitamin Shoppe, independent retailers. The brand trust is real and the 50-year track record buys real downside protection on QC.
What it doesn't buy: patent-tier active density. Label truth (corrected 27 Aug 2026): the panel does declare the actives — '470 mg (Supplying 7 mg [1.5%] Withanolides)' — we originally called it undisclosed. 7 mg per cap is honest and verifiable, and it is a quarter of the ~30 mg KSM-66 trial load.
This puts the bottle in the same structural category as Himalaya (#9) — legitimate brand, low-density root preparation — but without Himalaya's USDA Organic differentiator. At $15/month it's $1 more than Nutricost KSM-66, which delivers the real Ixoreal patent + verified 5% withanolide standardisation at trial-exact dose. The 'consider' verdict reflects this: Solaray is a real product for specific buyer profiles (offline-preference, brand-loyalty, legacy-tier trust), not the right pick for the testosterone-trial-anchored evidence-led buyer.
The Supplement Facts panel declares '470 mg (Supplying 7 mg [1.5%] Withanolides)' — an honest, verifiable figure. (Corrected 27 Aug 2026: we originally called this undisclosed and estimated 4-9 mg; the label states 7 mg, inside that band.) Compared to KSM-66's contracted 5% (= 23.5 mg withanolides per 470 mg gram-weight equivalent), Solaray delivers ~30% of the trial-extract active load. Scores above the truly-undeclared tier for its plain declaration, but stays low on the criterion with 30% weight — the testosterone-trial evidence base runs on 4× this density.
Generic root extract from Solaray's established supply chain. No KSM-66 or Sensoril patent license, no Solaray-specific clinical trial on the testosterone endpoint, no direct anchoring to the published RCT evidence base. The 50-year brand longevity provides indirect QC consistency signal (no major recalls, no major scandals), which substitutes partially for trial-grade evidence — buyers can trust Solaray's bottle won't contain contaminants or wildly wrong dose, even if they can't trust it matches Wankhede 2015 / Lopresti 2019 active loads.
Solaray's label carries a 'Lab Verified' seal and the brand states it runs in-house QC labs and GMP-compliant manufacturing; neither GMP nor USP-testing detail is printed on this label, so that part is brand-stated rather than label-verified. The brand's 50-year operational continuity provides implicit batch-to-batch consistency that mass-market generic brands lack. Solaray does not publish per-batch COA lookup or per-lot withanolide verification. The transparency tier is solidly above mass-market generic (Nature's Bounty) and roughly comparable to Himalaya — a printed seal plus brand-stated QC rather than public per-batch lookup.
470 mg per cap is in the 300-600 mg gram-weight trial window for KSM-66 dosing, but the active-mg math is what matters: the declared 7 mg withanolides per cap is below the 12 mg active dose in Lopresti 2019 stress (240 mg KSM-66) and a quarter of the 30 mg active dose in Wankhede 2015 / Lopresti 2019 testosterone (600 mg KSM-66). At 1 cap/day Solaray undershoots every clinical-trial active dose; at 2 caps/day (14 mg, $30/month effective) it just passes the stress-trial load. Gram-weight alignment is OK, active-mg alignment is below trial doses.
$15/month at 1 cap/day (30 caps) = $0.50/cap = ~$0.071 per mg active withanolide at the declared 7 mg/cap — roughly nine times Nutricost's $0.0078/mg for KSM-66 actives, and above NOW Foods' 2.5% tier as well. (Corrected 27 Aug 2026: our earlier $0.03-0.06 band used an undeclared 4-9 mg estimate; the label pins it at 7 mg. Corrected 3 Sep 2026: the per-cap price had been miswritten as $0.25/cap — $15/month at 1 cap/day is $0.50/cap; the $0.071/mg figure was already correct.) Fair price for the legacy-brand trust + offline availability premium; on pure active-mg economics, Nutricost KSM-66 at $14 wins the comparison outright.
“Made by Solaray — over 50 years of supplement experience.”
Solaray was founded in 1973 — verifiable corporate history with 50+ years of continuous operation as of 2026. The brand-heritage claim is literal historical fact.
“+Herbal Support (front-label claim; 'supports a healthy stress response' is Amazon-listing language, not printed on the label).”
Possible at 2 caps/day = 14 mg declared withanolides, just past the Lopresti 2019 stress active dose (12 mg withanolides). At 1 cap/day (7 mg) the active load is below every clinical-trial dose. The label itself only prints '+Herbal Support‡'; the specific stress-response wording comes from the Amazon listing. Generic adaptogen mechanism is real at patent-extract concentrations, partial at this concentration.
“Lab tested for purity and potency.”
Internal QC testing is verified — Solaray runs heavy-metals and microbial assays, and the label gives the potency spec to test against: 7 mg (1.5%) withanolides per cap. (Corrected 27 Aug 2026: we originally wrote there was no declared percentage.) What remains internal is the per-lot documentation — no public COA lookup — so 'tested for potency' is credible against a declared spec, verified in-house rather than externally.
“Vegan, gluten-free.”
'Vegan' is verified — a round Vegan seal is printed on the front label, and the capsule is vegetable cellulose. 'Gluten-free' is not printed anywhere on the label; it's only inferable from the Other Ingredients list (vegetable cellulose capsule, cellulose, magnesium stearate, silica — no gluten-containing inactives), so treat it as unconfirmed rather than a label-certified claim.
“Traditionally used to help support energy.”
Traditional Ayurvedic use of ashwagandha for energy/vitality is documented historically. Marketing language is regulator-safe and substantively accurate at the traditional-use level; the modern RCT evidence base is on standardised extracts, not on this preparation specifically.
An earlier version of this review said Solaray 'has never published a withanolide percentage,' that the extract is 'non-standardised,' and that the concentration 'isn't disclosed' — in the FAQs, the skip-if list, the specs table, and a con line. The Supplement Facts panel reads: '470 mg (Supplying 7 mg [1.5%] Withanolides)' — the same figure the front label prints as '470 mg | 1.5% Withanolides'. We re-read the label on Sep 3, 2026 and revised the text throughout the review; the overallScore (6.8) does not change, because the Standardisation and Price-per-active-mg sub-scores already used the declared 7 mg figure — only the reader-facing prose was corrected.
Founded 1973, Solaray has operated continuously through 50+ years of US supplement industry consolidation. They've built into Sprouts, Whole Foods, Vitamin Shoppe, and most independent health stores; their 1000+ SKU range gives the brand institutional QC discipline. No major recalls, no major QC scandals, no major regulatory actions across the half-century run. This is real downside protection — you can buy Solaray confident the bottle won't contain contaminants or wildly wrong gram dose. Per-cap active content IS declared (7 mg, 1.5% withanolides) — what you can't be confident about is whether any given bottle actually hits that number, because there's no public per-lot COA to confirm it. Brand reputation is QC consistency, not per-lot actives verification.
Solaray and Himalaya (#9) are structurally similar bottles: low-density root preparations with honestly-declared actives, brand-trust-based QC, retail-tier distribution. Himalaya carries USDA Organic certification (both brands are Non-GMO Project Verified); Solaray counters with a higher declared active load — 7 mg per cap versus Himalaya's ~3 mg per caplet — which is why Solaray now ranks the spot above Himalaya (both corrected 27 Aug 2026 after reading the panels; we had previously called both undeclared and ranked Solaray below). Between the two, pick by what matters more: USDA Organic certification (Himalaya) or more than double the declared withanolides per pill (Solaray).
For $1/month less than Solaray, Nutricost delivers: real Ixoreal-licensed KSM-66 patent, verified 5% withanolide standardisation, full 30 mg active withanolide dose per 600 mg cap, trial-exact dose for Wankhede 2015 / Lopresti 2019. The only structural reason to pick Solaray over Nutricost at this price tier is offline availability — Nutricost is Amazon-only, Solaray is in every health food store. For buyers who shop offline or have established brand loyalty, Solaray's $1 premium is reasonable. For buyers who shop Amazon and optimise for active-load-per-dollar, Nutricost wins the comparison decisively.
The label pins the number: 7 mg (1.5%) withanolides per 470 mg cap. The Lopresti 2019 stress trial used 240 mg KSM-66 (12 mg withanolides) for a -23% cortisol drop; Solaray at 1 cap/day delivers ~58% of that active load. The Wankhede 2015 / Lopresti 2019 testosterone trials used 600 mg KSM-66 (30 mg withanolides); Solaray at 1 cap/day delivers ~23% of that. At 2 caps/day (14 mg, $30/month effective) Solaray just passes the stress-trial active load but exceeds the price of patent-licensed alternatives. The active-mg math doesn't favour this bottle for primary protocols.
Three legitimate buyer profiles: (1) Offline shoppers — you want a bottle from the health food store you already shop at, not from Amazon. (2) Established brand-stack users — you already run Solaray's other products (B-vitamins, magnesium, herbs) and want supply-chain consistency across your supplement protocol. (3) Generic-brand-distrust philosophical position — you've decided not to buy from new/budget brands (Nutricost was founded 2014, Nature's Bounty's QC is mass-market) and want a 50-year US legacy company instead. For any of these, Solaray is a coherent choice despite the standardisation gap. Outside these, the comparison math goes against this bottle.
Solaray Ashwagandha is a coherent product for buyers who weight 50-year US-brand reputation + retail availability over patent-extract standardisation. The brand longevity is real — founded 1973, Solaray has operated continuously through 50+ years of US supplement industry consolidation without major recalls, QC scandals, or regulatory actions. They've built into nearly every American health food store, their 1000+ SKU range carries institutional QC discipline, and the in-house labs plus brand-stated GMP-compliant manufacturing provide real downside protection. For offline shoppers, established brand-stack users, and buyers who philosophically distrust generic-budget options, Solaray clears the relevant bars. The 'consider' verdict reflects two structural problems for the testosterone-trial evidence-led buyer. First: active density. The panel declares 7 mg (1.5%) withanolides per cap (corrected 27 Aug 2026 — we originally called it undisclosed) — below the Lopresti 2019 stress active dose (12 mg) and well below the Wankhede 2015 / Lopresti 2019 testosterone dose (30 mg). The active-mg math doesn't reach trial concentrations at 1 cap/day. Second: the $15/month price point is $1 above Nutricost KSM-66 at $14, which delivers the real Ixoreal-licensed patent, verified 5% withanolide standardisation, and full 30 mg active dose at trial-exact dose. For buyers optimising for active-load-per-dollar, Nutricost wins the comparison cleanly. The honest framing: pick Solaray when retail-tier brand trust + offline availability are the deciding criteria. Pick Nutricost KSM-66 at the same price tier when testosterone-trial evidence anchoring is the priority. Pick Himalaya (#9) at ~$6.50/month when USDA Organic certification is the differentiator that matters. Solaray's spot at #8 reflects the corrected label reading: its declared 7 mg per cap is more than double Himalaya's ~3 mg, which lifted it a place, while the trial-anchored density gap still keeps it beneath every standardised pick.
Affiliate link — Super Achiever Club earns a small commission at no extra cost to you.
The direct $1-cheaper alternative — real Ixoreal patent + verified 5% withanolides + 600 mg trial-exact dose at $14/month. The decisive choice over Solaray for the testosterone-trial evidence-led buyer at the same price tier.
See it on the list →The traditional-source pick at ~$6.50/month — USDA Organic + Non-GMO Project Verified + direct India Ayurvedic supply chain, with ~3 mg declared withanolides per caplet. The right call if organic certification outranks active density.
See it on the list →The household-brand pick at $10/month — published 2.5% withanolide standardisation (11 mg/cap) + NOW's in-house QC pedigree. Cheaper than Solaray with a higher declared active load.
See it on the list →600 mg/day KSM-66 (= 30 mg withanolides) for 8 weeks in resistance-trained men measured serum testosterone +96 ng/dL. Cited as the active-load benchmark — Solaray's declared 7 mg withanolides at 1 cap/day is well below this trial dose.
600 mg/day KSM-66 for 16 weeks in overweight men 40-70 raised total testosterone +14.7% and DHEA-S +18%. The cornerstone testosterone-trial active load Solaray's 1.5% extract (7 mg/cap) doesn't reach at 1 cap/day.
600 mg/day KSM-66 for 60 days in chronically stressed adults reduced perceived stress -44% and morning cortisol -27.9%. Patent-extract benchmark — Solaray's preparation has no parallel published RCT.
240 mg/day KSM-66 (= 12 mg withanolides) for 60 days lowered cortisol -23%. Active-load benchmark Solaray at 1 cap/day undershoots; at 2 caps/day it overlaps the bottom of the trial-active band but at higher effective cost than patent alternatives.
KSM-66 600 mg/day for 8 weeks in healthy adults improved sleep quality and reduced anxiety — the standardised-extract benchmark for general wellness endpoints that Solaray's low-standardisation (1.5%) extract doesn't directly inherit.
125-250 mg/day Sensoril (10% withanolides) reduced cortisol -24.2%. Demonstrates the role of standardised concentration in predictable dose-response — Solaray's 1.5% extract sits far below Sensoril's 10% concentration.